慢性心力衰竭患者的肌少症与内皮功能:SICA-HF研究
本研究为横断面研究,纳入228例心衰患者和32例对照,评估肌少症对射血分数降低和保留心衰患者内皮功能的影响。结果显示肌少症患者前臂基础血流更低,且心衰患者峰值血流均低于对照,峰值血流与运动能力相关。
要点
- 心衰患者中肌少症患病率为19.5%,肌少症患者前臂基础血流更低。
- 心衰患者(无论有无肌少症)前臂和腿部峰值血流均低于对照。
- 腿部峰值血流与6分钟步行距离独立相关。
核心结论
- 合并肌少症的心衰患者存在内皮功能障碍,血管舒张功能降低对运动能力有负面影响。
研究设计与样本
- 横断面研究,纳入228例心衰患者和32例对照,参与者来自SICA-HF研究。
主要发现
- 肌少症见于37例患者(19.5%)。
- 肌少症患者前臂基础血流为2.30 ± 1.21 mL min-1 100 mL-1,低于无肌少症患者的3.06 ± 1.49 mL min-1 100 mL-1和对照的4.00 ± 1.66 mL min-1 100 mL-1(P = .02)。
- 肌少症患者腿部基础血流为2.06 ± 1.62 mL min-1 100 mL-1,与无肌少症患者(2.39 ± 1.39 mL min-1 100 mL-1)相似(P = .11),但低于对照(2.99 ± 1.28 mL min-1 100 mL-1;P = .03)。
- 有和无肌少症患者前臂峰值血流分别为18.37 ± 7.07和22.19 ± 8.64 mL min-1 100 mL-1,均低于对照的33.63 ± 8.57 mL min-1 100 mL-1(P < .001);腿部峰值血流分别为10.89 ± 5.61和14.66 ± 7.19 mL min-1 100 mL-1,均低于对照的21.37 ± 13.16 mL min-1 100 mL-1(P < .001)。
- 前臂峰值血流与相对峰值VO2(R = 0.47;P < .001)、绝对峰值VO2(R = 0.35;P < .001)和6分钟步行距离(R = 0.20;P < .01)显著相关;腿部峰值血流与绝对峰值VO2(R = 0.42,P < .001)、相对峰值VO2(R = 0.41,P < .001)和6分钟步行试验(R = 0.33,P < .001)也相关。
临床怎么用
- 对心衰患者应关注肌少症筛查,肌少症可能提示内皮功能障碍和运动能力下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Skeletal muscle wasting, also known as sarcopenia, has recently been identified as a serious comorbidity in patients with heart failure (HF). We aimed to assess the impact of sarcopenia on endothelial dysfunction in patients with HF with reduced ejection fraction (HFrEF) and with preserved ejection fraction (HFpEF). DESIGN: Cross-sectional study. SETTING: Ambulatory patients with HF were recruited at Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany. PARTICIPANTS: We assessed peripheral blood flow (arm and leg) in 228 patients with HF and 32 controls who participated in the Studies Investigating Comorbidities Aggravating HF (SICA-HF). MEASUREMENTS: The appendicular skeletal muscle mass of the arms and the legs combined was assessed by dual energy x-ray absorptiometry (DEXA). Sarcopenia was defined as the appendicular muscle mass two standard deviations below the mean of a healthy reference group of adults aged 18 to 40 years, as suggested for the diagnosis of muscle wasting in healthy aging. All patients underwent a 6-minute walk test and spiroergometry testing. Forearm and leg blood flow were measured by venous occlusion plethysmography. Peak blood flow was assessed after a period of ischemia in the limbs to test endothelial function. RESULTS: Sarcopenia was identified in 37 patients (19.5%). Patients with sarcopenia presented with lower baseline forearm blood flow (2.30 ± 1.21 vs. 3.06 ± 1.49 vs. 4.00 ± 1.66 mL min-1 100 mL-1; P = .02) than those without sarcopenia or controls. The group of patients with sarcopenia showed similar baseline leg blood flow (2.06 ± 1.62 vs. 2.39 ± 1.39 mL min-1 100 mL-1; P = .11) to those without but lower values when compared to controls (2.06 ± 1.62 vs. 2.99 ± 1.28 mL min-1 100 mL-1; P = .03). In addition, patients with and without sarcopenia presented with lower peak flow in the forearm when compared to controls (18.37 ± 7.07 vs. 22.19 ± 8.64 vs. 33.63 ± 8.57 mL min-1 100 mL-1; P < .001). A similar result was observed in the leg (10.89 ± 5.61 vs. 14.66 ± 7.19 vs. 21.37 ± 13.16 mL min-1 100 mL-1; P < .001). Peak flow in the forearm showed a significant correlation with exercise capacity (relative peak VO2: R = 0.47; P < .001; absolute peak VO2: R = 0.35; P < .001; and 6-min walk distance: R = 0.20; P < .01). Similar correlations were observed between peak flow in the leg and exercise capacity (absolute peak VO2: R = 0.42, P < .001; relative peak VO2: R = 0.41, P < .001; and 6-min walk test: R = 0.33; P < .001). Logistic regression showed peak flow in the leg to be independently associated with the 6-min walk distance adjusted for age, hemoglobin level, albumin, creatinine, presence of sarcopenia, and coronary artery disease (hazard ratio, 0.903; 95% confidence interval, 0.835-0.976; P = .01). CONCLUSION: Patients with HF associated with sarcopenia have impaired endothelial function. Lower vasodilatation had a negative impact on exercise capacity, particularly prevalent in patients with sarcopenia.
引用
- Dos Santos MR, Saitoh M, Ebner N, et al. Sarcopenia and Endothelial Function in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF). J Am Med Dir Assoc. 2016. PMID: 27816483. doi:10.1016/j.jamda.2016.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。